The collaboration with DZNE, Munich is coordinated through Translational Neurodegeneration Department. For five years MERC and DZNE has been involved in DAAD funded projects to characterize genetic and epidemiological factors controlling Parkinson’s disease.
For about four years, MERC in collaboration with Pharmacology and Cancer Biology, Duke University, are trying to develop new biomarkers for diagnosis of brain damage. The collaboration has been generously funded by IBRO, ISN, Mansoura University Competitive Grants Program and Academy of Scientific Research and Technology (ASRT).
LCSB and MERC are currently involved in establishment of a new bioinformatic center and integrated biobank for future application in research in the biomedical field.
MERC is currently the newest member of GeoPD and is considered the first member in the Middle East. The main goal of this collaboration is to identify novel environmental and genetic risk factors for PD in Africa.
MERC and DNBM, VERONA is collaborating in promoting the teaching and research in the field of neuroscience.
This collaboration aims to explore the possibility of applying nanotechnology in regenerative Medicine.